Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Neurology | Psychiatry/Psychology | Musculoskeletal
Tardive Dyskinesia Clinical Trials
A listing of Tardive Dyskinesia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Arkansas
Little Rock : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
California
Anaheim : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Carson : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Colton : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Costa Mesa : Updated
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
Costa Mesa : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
View More »
Downey : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Fountain Valley : Updated
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
Fountain Valley : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Glendale : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
National City : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Oceanside : Updated
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
Oceanside : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Paramount : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
San Bernadino : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
San Diego : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Santa Ana : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Florida
Fort Lauderdale : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Hialeah : Updated
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
Hialeah : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Lauderhill : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Melbourne : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
View More »
Miami : Updated
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
Miami Springs : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
North Miami : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Orange City : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Georgia
Atlanta : NeuroTrials Research, Inc.
Tardive Dyskinesia in Schizophrenic Patients
View More »
Atlanta : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Illinois
Chicago : Updated
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
Chicago : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Schaumburg : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Louisiana
New Orleans : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Shreveport : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Maryland
Baltimore : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Glen Burnie : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Michigan
Farmington Hills : Updated
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
Missouri
St. Louis : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
New Jersey
Toms River : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Ohio
Beachwood : Updated
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
Beachwood : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Middleburg Heights : Updated
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
Oklahoma
Oklahoma City : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Pennsylvania
Conshohocken : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Conshohoken : Updated
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
Phoenixville : Updated
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
South Carolina
Charleston : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Tennessee
Memphis : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Texas
DeSoto : Updated
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
DeSoto : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Houston : Updated
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
Irving : Updated
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
Irving : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Washington
Bothell : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Canada
Toronto : Centre for Addiction and Mental Health
Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia
Victoria : Vancouver Island Health Authority
Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia
Windsor : Windsor Regional Hospital
Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia
India
Chennai : Schizophrenia Research Foundation (SCARF) Mental Health Centre
Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia
Puerto Rico
Caguas : Updated
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
